Gavi's balancing act: Accelerating access to vaccines while ensuring robust national decision-making for sustainable programmes
Since its creation in 2000, Gavi, the Vaccine Alliance has leveraged its public-private structure - bringing together governments, UN agencies, private sector and civil society - to make new and underused vaccines more affordable and accessible to people in lower-income countries. With cost barriers...
Gespeichert in:
| Veröffentlicht in: | Vaccine 2015-05, Vol.33, p.A4-A5 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | A5 |
|---|---|
| container_issue | |
| container_start_page | A4 |
| container_title | Vaccine |
| container_volume | 33 |
| creator | Sosler, Stephen Kallenberg, Judith Johnson, Hope L |
| description | Since its creation in 2000, Gavi, the Vaccine Alliance has leveraged its public-private structure - bringing together governments, UN agencies, private sector and civil society - to make new and underused vaccines more affordable and accessible to people in lower-income countries. With cost barriers largely removed, lower-income countries have embraced the opportunity to seek support for the introduction of life-saving vaccines. Since the initial Gavi-supported introductions of monovalent Hepatitis B vaccine in 2001, the picture has evolved significantly. |
| doi_str_mv | 10.1016/j.vaccine.2014.12.051 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1677891447</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0264410X1401706X</els_id><sourcerecordid>1677891447</sourcerecordid><originalsourceid>FETCH-LOGICAL-c448t-f7ec110d4e5f5926b9657e498b7879fe081a0455be823fa7547338893dc06a723</originalsourceid><addsrcrecordid>eNqFkk9v1DAQxS0EosvCRwBZ4gCXBE9ixw4HUFVBQarEAZB6sxxnUrzNn-JJFvXEV8dhF5B64WTL_r0ZvXnD2FMQOQioXu3yvfM-jJgXAmQORS4U3GMbMLrMCgXmPtuIopKZBHF5wh4R7YQQqoT6ITspVA016GLDfp67fXhBvHG9G1O5K-78_Jqfeo89RjcfXjwS8Xnix5bEf3wLPXIcaYkrEadmoZmPiZ9G1_MWfaB0zQZ3vf53U-SUCBdG1yThTZyuohsGpMfsQed6wifHc8u-vn_35exDdvHp_OPZ6UXmpTRz1mn0AKKVqDpVF1VTV0qjrE2jja47FAackEo1aIqyc1pJXZbG1GXrReV0UW7Zy0Pd1Pr7gjTbIVDymFzjtJCFSmtTg0y6LXt-B91NS0y2flNSg1baJEodKB8nooidvYlhcPHWgrBrQnZnj-Oya0IWCpsSSrpnx-pLM2D7V_UnkgS8PQCYxrEPGC35gKPHNkT0s22n8N8Wb-5U8H0Yg3f9Nd4i_XNjKQns53VN1i0BKUCL6rL8BTzvulc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1674717578</pqid></control><display><type>article</type><title>Gavi's balancing act: Accelerating access to vaccines while ensuring robust national decision-making for sustainable programmes</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><source>ProQuest Central UK/Ireland</source><creator>Sosler, Stephen ; Kallenberg, Judith ; Johnson, Hope L</creator><creatorcontrib>Sosler, Stephen ; Kallenberg, Judith ; Johnson, Hope L</creatorcontrib><description>Since its creation in 2000, Gavi, the Vaccine Alliance has leveraged its public-private structure - bringing together governments, UN agencies, private sector and civil society - to make new and underused vaccines more affordable and accessible to people in lower-income countries. With cost barriers largely removed, lower-income countries have embraced the opportunity to seek support for the introduction of life-saving vaccines. Since the initial Gavi-supported introductions of monovalent Hepatitis B vaccine in 2001, the picture has evolved significantly.</description><identifier>ISSN: 0264-410X</identifier><identifier>EISSN: 1873-2518</identifier><identifier>DOI: 10.1016/j.vaccine.2014.12.051</identifier><identifier>PMID: 25919172</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Allergy and Immunology ; Capital Financing - organization & administration ; Communicable Diseases - economics ; Communicable Diseases - epidemiology ; Costs and Cost Analysis ; Decision making ; Decision Support Techniques ; Health Policy ; Humans ; Immunization ; Immunization Programs - economics ; Immunization Programs - organization & administration ; Lifesaving ; Private sector ; Vaccination - economics ; Vaccination - methods ; Vaccines ; Vaccines - administration & dosage ; Vaccines - economics ; Vaccines - immunology</subject><ispartof>Vaccine, 2015-05, Vol.33, p.A4-A5</ispartof><rights>2015</rights><rights>Copyright Elsevier Limited May 7, 2015</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c448t-f7ec110d4e5f5926b9657e498b7879fe081a0455be823fa7547338893dc06a723</citedby><cites>FETCH-LOGICAL-c448t-f7ec110d4e5f5926b9657e498b7879fe081a0455be823fa7547338893dc06a723</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/1674717578?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995,64385,64387,64389,72469</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25919172$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sosler, Stephen</creatorcontrib><creatorcontrib>Kallenberg, Judith</creatorcontrib><creatorcontrib>Johnson, Hope L</creatorcontrib><title>Gavi's balancing act: Accelerating access to vaccines while ensuring robust national decision-making for sustainable programmes</title><title>Vaccine</title><addtitle>Vaccine</addtitle><description>Since its creation in 2000, Gavi, the Vaccine Alliance has leveraged its public-private structure - bringing together governments, UN agencies, private sector and civil society - to make new and underused vaccines more affordable and accessible to people in lower-income countries. With cost barriers largely removed, lower-income countries have embraced the opportunity to seek support for the introduction of life-saving vaccines. Since the initial Gavi-supported introductions of monovalent Hepatitis B vaccine in 2001, the picture has evolved significantly.</description><subject>Allergy and Immunology</subject><subject>Capital Financing - organization & administration</subject><subject>Communicable Diseases - economics</subject><subject>Communicable Diseases - epidemiology</subject><subject>Costs and Cost Analysis</subject><subject>Decision making</subject><subject>Decision Support Techniques</subject><subject>Health Policy</subject><subject>Humans</subject><subject>Immunization</subject><subject>Immunization Programs - economics</subject><subject>Immunization Programs - organization & administration</subject><subject>Lifesaving</subject><subject>Private sector</subject><subject>Vaccination - economics</subject><subject>Vaccination - methods</subject><subject>Vaccines</subject><subject>Vaccines - administration & dosage</subject><subject>Vaccines - economics</subject><subject>Vaccines - immunology</subject><issn>0264-410X</issn><issn>1873-2518</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkk9v1DAQxS0EosvCRwBZ4gCXBE9ixw4HUFVBQarEAZB6sxxnUrzNn-JJFvXEV8dhF5B64WTL_r0ZvXnD2FMQOQioXu3yvfM-jJgXAmQORS4U3GMbMLrMCgXmPtuIopKZBHF5wh4R7YQQqoT6ITspVA016GLDfp67fXhBvHG9G1O5K-78_Jqfeo89RjcfXjwS8Xnix5bEf3wLPXIcaYkrEadmoZmPiZ9G1_MWfaB0zQZ3vf53U-SUCBdG1yThTZyuohsGpMfsQed6wifHc8u-vn_35exDdvHp_OPZ6UXmpTRz1mn0AKKVqDpVF1VTV0qjrE2jja47FAackEo1aIqyc1pJXZbG1GXrReV0UW7Zy0Pd1Pr7gjTbIVDymFzjtJCFSmtTg0y6LXt-B91NS0y2flNSg1baJEodKB8nooidvYlhcPHWgrBrQnZnj-Oya0IWCpsSSrpnx-pLM2D7V_UnkgS8PQCYxrEPGC35gKPHNkT0s22n8N8Wb-5U8H0Yg3f9Nd4i_XNjKQns53VN1i0BKUCL6rL8BTzvulc</recordid><startdate>20150507</startdate><enddate>20150507</enddate><creator>Sosler, Stephen</creator><creator>Kallenberg, Judith</creator><creator>Johnson, Hope L</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7T2</scope><scope>7T5</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20150507</creationdate><title>Gavi's balancing act: Accelerating access to vaccines while ensuring robust national decision-making for sustainable programmes</title><author>Sosler, Stephen ; Kallenberg, Judith ; Johnson, Hope L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c448t-f7ec110d4e5f5926b9657e498b7879fe081a0455be823fa7547338893dc06a723</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Allergy and Immunology</topic><topic>Capital Financing - organization & administration</topic><topic>Communicable Diseases - economics</topic><topic>Communicable Diseases - epidemiology</topic><topic>Costs and Cost Analysis</topic><topic>Decision making</topic><topic>Decision Support Techniques</topic><topic>Health Policy</topic><topic>Humans</topic><topic>Immunization</topic><topic>Immunization Programs - economics</topic><topic>Immunization Programs - organization & administration</topic><topic>Lifesaving</topic><topic>Private sector</topic><topic>Vaccination - economics</topic><topic>Vaccination - methods</topic><topic>Vaccines</topic><topic>Vaccines - administration & dosage</topic><topic>Vaccines - economics</topic><topic>Vaccines - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sosler, Stephen</creatorcontrib><creatorcontrib>Kallenberg, Judith</creatorcontrib><creatorcontrib>Johnson, Hope L</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nursing & Allied Health Database</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Vaccine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sosler, Stephen</au><au>Kallenberg, Judith</au><au>Johnson, Hope L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Gavi's balancing act: Accelerating access to vaccines while ensuring robust national decision-making for sustainable programmes</atitle><jtitle>Vaccine</jtitle><addtitle>Vaccine</addtitle><date>2015-05-07</date><risdate>2015</risdate><volume>33</volume><spage>A4</spage><epage>A5</epage><pages>A4-A5</pages><issn>0264-410X</issn><eissn>1873-2518</eissn><abstract>Since its creation in 2000, Gavi, the Vaccine Alliance has leveraged its public-private structure - bringing together governments, UN agencies, private sector and civil society - to make new and underused vaccines more affordable and accessible to people in lower-income countries. With cost barriers largely removed, lower-income countries have embraced the opportunity to seek support for the introduction of life-saving vaccines. Since the initial Gavi-supported introductions of monovalent Hepatitis B vaccine in 2001, the picture has evolved significantly.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>25919172</pmid><doi>10.1016/j.vaccine.2014.12.051</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0264-410X |
| ispartof | Vaccine, 2015-05, Vol.33, p.A4-A5 |
| issn | 0264-410X 1873-2518 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1677891447 |
| source | MEDLINE; Access via ScienceDirect (Elsevier); ProQuest Central UK/Ireland |
| subjects | Allergy and Immunology Capital Financing - organization & administration Communicable Diseases - economics Communicable Diseases - epidemiology Costs and Cost Analysis Decision making Decision Support Techniques Health Policy Humans Immunization Immunization Programs - economics Immunization Programs - organization & administration Lifesaving Private sector Vaccination - economics Vaccination - methods Vaccines Vaccines - administration & dosage Vaccines - economics Vaccines - immunology |
| title | Gavi's balancing act: Accelerating access to vaccines while ensuring robust national decision-making for sustainable programmes |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T05%3A02%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Gavi's%20balancing%20act:%20Accelerating%20access%20to%20vaccines%20while%20ensuring%20robust%20national%20decision-making%20for%20sustainable%20programmes&rft.jtitle=Vaccine&rft.au=Sosler,%20Stephen&rft.date=2015-05-07&rft.volume=33&rft.spage=A4&rft.epage=A5&rft.pages=A4-A5&rft.issn=0264-410X&rft.eissn=1873-2518&rft_id=info:doi/10.1016/j.vaccine.2014.12.051&rft_dat=%3Cproquest_cross%3E1677891447%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1674717578&rft_id=info:pmid/25919172&rft_els_id=S0264410X1401706X&rfr_iscdi=true |